These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9058463)

  • 1. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
    Kayser SR
    Prog Cardiovasc Nurs; 1997; 12(1):39-43. PubMed ID: 9058463
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic conversion of atrial fibrillation and atrial flutter to normal sinus rhythm: the role of ibutilide.
    Katcher MS; Estes NA
    Pharmacotherapy; 1997; 17(1):177-80. PubMed ID: 9017781
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
    Hoyer AW; Balaji S
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):1003-8. PubMed ID: 17669084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
    Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
    Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid cardioversion of new onset atrial fibrillation with ibutilide in the emergency department.
    Ryan DT; Cummins FH; Fahy GJ
    Ir Med J; 2005 Sep; 98(8):241-2. PubMed ID: 16255117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter.
    Rogers KC; Wolfe DA
    J Emerg Med; 2001 Jan; 20(1):67-71. PubMed ID: 11165840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful termination of atrial flutter by ibutilide during pregnancy.
    Burkart TA; Kron J; Miles WM; Conti JB; Gonzalez MD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):283-6. PubMed ID: 17338730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of acute wide QRS complex atrial fibrillation with ibutilide.
    Sobel RM; Dhruva NN
    Am J Emerg Med; 2000 Jul; 18(4):462-4. PubMed ID: 10919540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using ibutilide to convert atrial fibrillation and flutter.
    Sargent DA
    Dimens Crit Care Nurs; 1999; 18(4):2-12. PubMed ID: 10640022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: acute treatment of atrial fibrillation and flutter--ibutilide in perspective.
    Waldo AL; Pratt CM
    Am J Cardiol; 1996 Oct; 78(8A):1-2. PubMed ID: 8903268
    [No Abstract]   [Full Text] [Related]  

  • 18. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
    Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
    Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter.
    Zaqqa M; Afshar H; Rasekh A; Khoshnevis R; Vaughn WK; Massumi A
    Am J Cardiol; 2000 Jan; 85(1):112-4, A9. PubMed ID: 11078250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation.
    Doggrell SA; Hancox JC
    Expert Opin Investig Drugs; 2005 May; 14(5):655-69. PubMed ID: 15926871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.